ZBH logo

ZIMMER BIOMET HOLDINGS INC

ZBHNYSE
πŸ† #548 by market capUS Equity
β€”β€”
Quote unavailable
πŸ””
Track ZBH
Get earnings, price moves & breaking news on Telegram
Track
24hβ€”
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
$18.80B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
8.6%
Slowing
πŸ“ŠGross Margin
69.9%
High
πŸ’΅FCF Margin
12.7%
Healthy
βš–οΈP/S Ratio
2.2x
Cheap
Otter Score
88
Excellent
No chart data available for ZBH.

Trading Snapshot

Day Range
β€”
52-Week Range
$79.12 – $104.15
Volume (shares)
β€”
Avg Volume (shares)
β€”
Shares Outstanding
190.7M
Next Earnings
β€”

Fundamentals Snapshot

Annual Revenue
$8.23B
Last Q Revenue
$2.18B
P/E Ratio
22.8
P/S Ratio
2.2x
EPS (TTM)
$4.11
Dividend Yield
1.02%
Dilution (1yr)
βˆ’0.9%
ZBH logo

ZIMMER BIOMET HOLDINGS INC

ZBH
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$8.2Bβ–² +7.2% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
61.6%β–Ό βˆ’13.8% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$1.4Bβ–² +6.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$1.5Bβ–² +28.9% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
198.1Mβ–Ό βˆ’0.9% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$6.9Bβ–Ό βˆ’$1.2B YoY
StockOtter Β· stockotter.space

About ZIMMER BIOMET HOLDINGS INC

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Excellent
88/100
Analyst data unavailable.

Latest News & Updates

News unavailable.